Patents by Inventor David J. PALLING

David J. PALLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10179781
    Abstract: Provided herein are sodium channel modulating Compounds, in particular NaV1.7 modulating compounds of Formula I: In particular, provided herein are processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions comprising, and therapeutic methods comprising administering such compounds. In particular, provided herein are compounds for the treatment of pain.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 15, 2019
    Inventors: Olga Babich, Robert Z. Luo, Yanlin Wang-Fischer, David J. Palling, Srinivasan P. Venkatachalan
  • Patent number: 9458118
    Abstract: Provided herein are sodium channel modulating Compounds, in particular NaV1.7 modulating compounds of Formula I or compounds of Formula I?: In particular, provided herein are processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions comprising, and therapeutic methods comprising administering such compounds. In particular, provided herein are compounds for the treatment of pain and diabetes.
    Type: Grant
    Filed: January 13, 2016
    Date of Patent: October 4, 2016
    Assignee: Chromocell Corporation
    Inventors: Olga Babich, Tina Garyantes, Robert Z. Luo, David J. Palling, Srinivasan P. Venkatachalan, Yanlin Wang-Fischer
  • Publication number: 20160221974
    Abstract: Provided herein are sodium channel modulating Compounds, in particular NaV1.7 modulating compounds of Formula I or compounds of Formula I?: In particular, provided herein are processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions comprising, and therapeutic methods comprising administering such compounds. In particular, provided herein are compounds for the treatment of pain and diabetes.
    Type: Application
    Filed: September 9, 2014
    Publication date: August 4, 2016
    Applicant: CHROMOCELL CORPORATION
    Inventors: Olga BABICH, Tina GARYANTES, Robert Z. LUO, David J. PALLING, Srinivasan P. VENKATACHALAN, Yanlin WANG-FISCHER
  • Publication number: 20160130239
    Abstract: Provided herein are sodium channel modulating Compounds, in particular NaV1.7 modulating compounds of Formula I or compounds of Formula I?: In particular, provided herein are processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions comprising, and therapeutic methods comprising administering such compounds. In particular, provided herein are compounds for the treatment of pain and diabetes.
    Type: Application
    Filed: January 13, 2016
    Publication date: May 12, 2016
    Applicant: CHROMOCELL CORPORATION
    Inventors: Olga BABICH, Tina GARYANTES, Robert Z. LUO, David J. PALLING, Srinivasan P. VENKATACHALAN, Yanlin WANG-FISCHER
  • Publication number: 20160046617
    Abstract: Provided herein are sodium channel modulating Compounds, in particular NaV1.7 modulating compounds of Formula I: In particular, provided herein are processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions comprising, and therapeutic methods comprising administering such compounds. In particular, provided herein are compounds for the treatment of pain.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 18, 2016
    Applicant: CHROMOCELL CORPORATION
    Inventors: Olga BABICH, Robert Z. LUO, Yanlin WANG-FISCHER, David J. PALLING, Srinivasan P. VENKATACHALAN